Fate Therapeutics
FATE
#9125
Rank
NZ$0.20 B
Marketcap
NZ$1.78
Share price
-4.67%
Change (1 day)
-23.34%
Change (1 year)

Market capitalization of Fate Therapeutics (FATE)

Market cap: NZ$0.20 Billion

As of January 2026 Fate Therapeutics has a market cap of NZ$0.20 Billion. This makes Fate Therapeutics the world's 9125th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Fate Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.20 B2.92%
2025NZ$0.19 B-38.74%
2024NZ$0.32 B-44.24%
2023NZ$0.58 B-62.24%
2022NZ$1.54 B-81.12%
2021NZ$8.18 B-25.6%
2020NZ$10.99 B399.63%
2019NZ$2.20 B77.84%
2018NZ$1.23 B173.24%
2017NZ$0.45 B201.98%
2016NZ$0.14 B6.06%
2015NZ$0.14 B7.08%
2014NZ$0.13 B-15.44%
2013NZ$0.15 B

End of Day market cap according to different sources

On Jan 12th, 2026 the market cap of Fate Therapeutics was reported to be:

NZ$0.21 Billion
by Nasdaq info icon info icon
NZ$0.21 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sarepta Therapeutics
SRPT
NZ$3.91 B 1,811.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
NZ$100.21 B 48,784.82%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
NZ$10.54 B 5,045.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
NZ$19.01 B 9,175.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$22.97 B 11,107.84%๐Ÿ‡บ๐Ÿ‡ธ USA